Executive function impairment in early-treated PKU subjects with normal mental development

Journal of Inherited Metabolic Disease

Volumn 27, Issue 2, 2004, Pages 115-125

  Leuzzi, Vincenzo ^a   Pansini, M ^a   Sechi, E ^a   Chiarotti, F ^b   Carducci, Cl ^a   Levi, G ^a   Antonozzi, I ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b National Health Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ADOLESCENT; AGE; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; BRAIN DYSFUNCTION; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; DIETARY INTAKE; FEMALE; FRONTAL LOBE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; INTELLIGENCE QUOTIENT; LEARNING TEST; LINEAR SYSTEM; MALE; MAZE TEST; MENTAL DEVELOPMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENYLKETONURIA; SCHOOL CHILD; SEX; SOCIAL STATUS; TASK PERFORMANCE; WISCONSIN CARD SORTING TEST;

ADOLESCENT; CHILD; COGNITION DISORDERS; FEMALE; FRONTAL LOBE; HUMANS; INTELLIGENCE; MALE; NEUROPSYCHOLOGICAL TESTS; PHENYLKETONURIAS; PROGNOSIS; SOCIAL CLASS;

EID: 2942598072     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BOLI.0000028781.94251.1f     Document Type: Article

References (40)

1. Ardila A, Pineda D, Rosselli M (2000) Correlation between intelligence test scores and executive function measures. Arch Clin Neuropsychol 15: 31-36.
2. Banich MT, Milham MP, Atchley R, et al (2000) Prefrontal regions play a predominant role in imposing an attentional 'set': evidence from tMRI. Cogn Brain Res 10: 1-9.
3. Berry H, O'Grady D, Perlmutter L, Bofinger M (1979) Intellectual development and academic achievement of children treated early for phenylketonuria. Dev Med Child Neurol 21: 311-320.
4. Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M (1987) Visual dysfunction in Parkinson's disease. Loss in spatio-temporal contrast sensivity. Brain 110: 1675-1698.
5. Borys SV, Spitz HH, Dorans BA (1982) Tower of Hanoi performance of retarded young adults and non-retarded children as a function of solution length and goal state. J Exp Child Psychol 33: 87-110.
6. Brosnan M, Demetre J, Hamill S, Robson K, Shepherd H, Cody G (2002) Executive functioning in adults and children with developmental dyslexia. Neuropsychologia 40: 2144-2155
7. Brunner RL, Jordan MK, Berry HK (1983) Early-treated phenylketonuria: neuropsychologic consequences. J Pediatr 102: 831-835.
8. Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155 (supplement 1): S33-S38.
9. Diamond A (1988) Abilities and neural mechanism underlying AB performance. Child Dev 59: 523-527.
10. Diamond A, Herzberg C (1996) Impaired sensivity to visual contrast in children treated early and continuously for phenylketonuria. Brain 119: 523-538.
11. Diamond A, Prevor M, Callender G, Druin D (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 62: serial no. 252.
12. Dobson J, Kushida E, Williamson M, Friedman E (1976) Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings. Pediatrics 58: 53-58.
13. Domenici L, Trimarchi C, Piccolino M, Fiorentini A, Maffei L (1985) Dopaminergic drugs improve human visual contrast sensitivity. Hum Neurobiol 4: 195-197.
14. Faust D, Libon D, Pueschel S (1986) Neuropsychological functioning in treated phenylketonuria. Int J Psychiatry Med 16: 169-177.
15. Feldman R, Denecke J, Pietsch M, Grenzebach M, Weglage J (2002) Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early treated patients in comparison to diabetic patients. Pediatr Res 51: 761-765.
16. Fisch RO, Chang PN, Weisberg S, Guldberg P, Guttler F, Tsai MY (1995) Phenylketonuria patients decades after diet. J Inherit Metab Dis 18: 347-353.
17. Fishler K, Azen C, Henderson R, Friedman EG, Koch R (1987) Psychoeducational findings among children treated for phenylketonuria. Am J Ment Defic 92: 65-73.
18. Fishler K, Azen C, Friedman EG, Koch R (1989) School achievement in treated PKU children. J Ment Defic Res 33: 493-498.
19. Gershberg FB, Shimamura AP (1995) Impaired use of organizational strategies in free recall following frontal lobe damage. Neuropsychologia 13: 1305-1333.
20. Goldman-Rakic PS (1987) Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In Plum F, ed. Handbook of Physiology: The Nervous System, Bethesda, MD: American Physiological Society, 373-417.
21. Hudson FP, Mordaunt VL, Leahy I (1970) Evaluation of treatment begun in first three months of life in 184 cases of phenylketonuria. Arch Dis Child 45: 5-12.
22. Koch R, Azen C, Friedman EG, Williamson ML (1984) Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age. J Inherit Metab Dis 7: 86-90.
23. Leuzzi V, Rinalduzzi S, Chiarotti F, Garzia P, Trasimeni G, Accornero N (1998) Subclinical visual impairment in phenylketonuria. A neuropsichological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations. J Inherit Metab Dis 21: 351-364.
24. Lezak MD (1983) Neuropsycological Assessment, 2nd edn. New York: Oxford University Press.
25. Luciana M, Sullivan J, Nelson CA (2001) Associations between phenylalanine-to-tyrosine ratios and performances on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria. Child Dev 71: 1637-1652.
26. Luria AR (1966) Higher Cortical Functions in Man. London: Tavistock.
27. Mazzocco MMM, Nord AM, Doorninck WV, Greene CL, Kovar CG, Pennington BF (1994) Cognitive development among children with early-treated phenylketonuria. Dev Neuropsychol 10: 133-151.
28. Miller EK, Cohen JD (2001) An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24: 167-202.
29. Milner B (1963) Effects of different brain lesions on card sorting. Arch Neurol 9: 90.
30. O'Flynn ME, Hsia DY (1968) Some observations on the dietary treatment of phenylketonuria. J Pediatr 72: 260-262.
31. Osterreith PA (1994) Le test de copie d'une figure complexe. Arch Psychol 30: 206-256.
32. Riva D, Saletti V, Nichelli F, Bulgheroni S (2002) Neuropsychological effects of frontal lobe epilepsy in children. J Child Neurol 17: 661-667.
33. Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, Sonneville L (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16: 681-688.
34. Shallice T (1982) Specific impairments of planning. Philos Trans R Soc London Ser B 298: 199-209.
35. Smith I, Wolff OH (1974) Natural history of phenylketonuria and influence of early treatment. Lancet 2: 540-544.
36. Smith I, Beasley MG, Ades AE (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65: 472-478.
37. Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana dei test neuropsicologici. Italian Journal of Neurological Sciences, supplement 8.
38. Swanson S (1993) Working memory in learning disability subgroups. J Exp Child Psychol 56: 87-114.
39. Waisbren SE, Brown MJ, Sonneville LMJ de, Levy HL (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr 83(supplement 407): 98-103.
40. Welsh MC, Pennington BF, Oznoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev 61: 1697-1713.